secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2025-07-30T23:59:59+00:00
Accession:  0001641172-25-021560
Event type: debt
Sentiment:  negative
Materiality: 0.40
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Propanc Biopharma enters $112,350 convertible note at 22% interest with 1800 Diagonal Lending
--------------------------------------------------------------------------------

- Issued $112,350 convertible promissory note to 1800 Diagonal Lending LLC at a 22% annual interest rate.
- Conversion price is 75% of average lowest trading price over 10 days prior to conversion, with 4.99% beneficial ownership cap.
- Maturity date April 30, 2026; company can prepay at 120% premium within 90 days, 125% from 91-180 days.
- Proceeds from $107,000 purchase price (after $5,350 original issue discount) used for general working capital.
- Events of default include failure to pay, failure to issue conversion shares, and loss of OTC listing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225021560/0001641172-25-021560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000164117225021560/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-021560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer